Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 12 Aug 2026 for TAKEDA PHARMACEUTICAL CO LTD, €1.3M.
Filing timeline
BuySaleJulie So-Young Kim
Insider track record
Disclosed buys
0
Disclosed sells
1
Signal history
No signal scores available.
Julie So-Young Kim: trading record in brief
Julie So-Young Kim discloses dealings in Takeda Pharmaceutical Co Ltd to SEC (Form 4). The record holds 4 filings, for trades running from 27 April 2026 to 10 August 2026.
No open-market purchase appears, only 1 sale worth €1.3M. Other entries cover 3 share grants.
The newest entry dates from 12 August 2026: an open-market sale of €1.3M, in Takeda Pharmaceutical Co Ltd. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Julie So-Young Kim
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
89,090 shares@ US$17.100.0025% mcap100.0% of flowAmerican Depositary SharesSEC:0001493152-26-037484:0
50,434 shares0American Depositary SharesSEC:0001395064-26-000246:0
22,800 shares0Ordinary SharesSEC:0001395064-26-000246:1
105,416 shares0American Depositary SharesSEC:0001395064-26-000128:0
4 of 4 declarations
